Tango Therapeutics, Inc. (TNGX) NASDAQ
21.50
-1.6(-6.93%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
21.50
-1.6(-6.93%)
Currency In USD
| Market Cap | 1.03B |
| Enterprise Value | 950.52M |
| P/E Ratio | -28.79 |
| PEG Ratio | -0.96 |
| Price/Sales Ratio | 43.83 |
| Price/Book Ratio | 7.88 |
| Enterprise/Revenue | 41.63 |
| Enterprise/EBITDA | -20.95 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -1.88 |
| Operating Margin | -2.06 |
| Return On Assets | -0.25 |
| Return On Equity | -0.42 |
| Revenue | 62.38M |
| Revenue/Share | 0.4 |
| Gross Profit | 60.1M |
| EBITDA | -109.01M |
| Net Income | -101.59M |
| Diluted EPS | -0.87 |
| Total Cash | 379.84M |
| Total Cash/Share | 2.65 |
| Total Debt | 32.79M |
| Total Debt/Equity | 0.08 |
| Current Ratio | 27.38 |
| Book Value Per Share | 2.73 |
| 52-Week Change | 563.58 |
| 52-Week High | 28.41 |
| 52-Week Low | 2.96 |
| Moving Average 50 Days | 22.38 |
| Moving Average 200 Days | 13.05 |
| Average Volume | 3.38M |
| Shares Outstanding | 116.17M |
| % Held by Institutions | 155.17 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |